Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
about
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club.Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreEarly stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.Bone targeted treatments in cancer - The story so farAssessment of bone health in breast cancer patients starting adjuvant aromatase inhibitors: A quality improvement clinical auditManagement of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGSt. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.Risk factors for bone metastasis in completely resected non-small-cell lung cancer.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Management of Potential Long-Term Toxicities in Breast Cancer Patients.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.Osteoclast inhibition in postmenopausal breast cancer: Is the evidence too strong to ignore?microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.Cancer Treatment and Bone Health.Evaluation and management of skeletal disease in cancer care.Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.Pharmacology: Sea change of indications.Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner
P2860
Q28068956-A23B28A0-D70E-40B7-8467-78CB637DA208Q30235173-F135133A-1F80-4158-8C7F-9DB014C2A36AQ33606741-DA7DE242-1313-4D50-861E-AF64817E3D54Q33792517-D78BBD88-2261-4B36-9DEE-A9704B6678B5Q33861323-548C1790-89FA-4807-8EF9-07E4131DBEDBQ37337487-B69A4264-1D6D-4301-9389-A5FF0817105AQ37499975-003D6178-3D25-41BC-83EC-B66767E27FABQ37742180-B5D549C1-4445-40B2-8490-25BEE45728D5Q38676979-C196B203-FD00-46EF-A6F1-06DC12AB3A76Q38793159-25613BE0-5FEE-456B-AB5A-CEA82AAC4FA3Q38968531-D9B0663C-5168-497D-B0A6-47ACDDECEAAFQ39305824-98119316-BA02-4C1F-B22E-429FB6CEF0C0Q40267794-8D664EB5-0735-43B6-90C9-95800B2195FBQ47673322-20F22092-2ED3-4D21-825A-280A3A83A1FCQ48207269-238F6E3F-5879-4088-9EFE-5889A31BA241Q48224625-6766C350-5735-4CBE-801B-46B290CA0306Q49211720-501E2CE7-C35B-404A-87D0-E700CD50AD64Q50070694-8440B970-F2F0-4BAE-ABEF-201EC36786CDQ50682230-FDEFA86F-71B6-4AA5-BE44-2C88F1DD9A7CQ53792283-34E3872F-A688-478B-A4F8-BF129666A503Q54978574-89A4FFB9-ED85-4AA6-A039-3ACAD9FD2323Q55322511-3683191C-F086-460F-9727-5DD2811B975FQ58757708-2723A0BC-4BAF-4205-A7DA-E10EADFE605C
P2860
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adjuvant bisphosphonates in ea ...... ractice from a European Panel.
@en
type
label
Adjuvant bisphosphonates in ea ...... ractice from a European Panel.
@en
prefLabel
Adjuvant bisphosphonates in ea ...... ractice from a European Panel.
@en
P2093
P50
P356
P1433
P1476
Adjuvant bisphosphonates in ea ...... ractice from a European Panel.
@en
P2093
B Ejlertsen
B Thurlimann
P304
P356
10.1093/ANNONC/MDV617
P577
2015-12-17T00:00:00Z